Indonesia examines use of Sinovac, Pfizer vaccines for children, youths

Whatsapp News

Indonesia said its currently examining use of both Sinovac and Pfizer for under 18 years of age.

Minister Budi Gunadi Sadikin said at a virtual news conference on Friday that examination of came after detecting many cases of highly contagious Delta variant of coronavirus among children and youths.

“We are currently reviewing which already have an EUA ( Use Authorisation) for young .

“What we have observed is that there are two on list; Sinovac for those aged three to 17 years old and Pfizer for those aged between 12 years and 17 years old.’’

has approved the use of the Sinovac for as young as three-year-olds, meanwhile the has approved Pfizer for those as young as 12.

Sadikin said Indonesian ministry had been conducting a study on vaccinating children, which would be released soon.

He said at the same time, the ministry had continued to observe the developments and data related to effectiveness and side effects of vaccines administered to children in a number of countries.

“We can issue a comprehensive decision based on the data we have, policy data in other countries and scientific data on the EUA that have been given to companies,’’ said Sadikin.

Under its , the Southeast Asian country is currently working to inoculate the targeted 181.5 million people aged over 18 years, about 70 per cent of its total by March 2022.